IPCALAB.NS

Ipca Laboratories Limited [IPCALAB.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

IPCALAB.NS Stock Summary

Top 10 Correlated ETFs

IPCALAB.NS

Top 10 Correlated Stocks

IPCALAB.NS

In the News

IPCALAB.NS Financial details

Company Rating
-
Market Cap
339.71B
Income
5.64B
Revenue
71.86B
Book val./share
-
Cash/share
-
Dividend
2
Dividend %
0.18%
Employees
16.17K
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
57.54
Forward P/E
-
PEG
-15.91
P/S
4.24
P/B
4.61
P/C
-
P/FCF
-
Quick Ratio
1.04
Current Ratio
2.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
22.25
EPS next Y
-
EPS next Q
-
EPS this Y
-46.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.08%
Revenue last 5Y
11.08%
Revenue Q/Q
0.93%
EPS Q/Q
23.95%
-
-
-
-
SMA20
10.38%
SMA50
6.06%
SMA100
0.11%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
16%
ROC
0.1%
Gross Margin
65%
Oper. Margin
13%
Profit Margin
7%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
669.8-1348.1
52W High
+8.24%
52W Low
+118.1%
RSI
60.95
Rel Volume
0.42
Avg Volume
563.32K
Volume
237.73K
Perf Week
3.56%
Perf Month
13.88%
Perf Quarter
5.5%
Perf Half Y
4.53%
-
-
-
-
Beta
0.23
-
-
Volatility
21.08%, 71.7%
Prev Close
0.31%
Price
1459.1
Change
1.68%

IPCALAB.NS Financial Performance

IPCALAB.NS Dividend History

IPCALAB.NS Frequently Asked Questions

What is Ipca Laboratories Limited stock symbol ?

Ipca Laboratories Limited is a IN stock and trading under the symbol IPCALAB.NS

What is Ipca Laboratories Limited stock quote today ?

Ipca Laboratories Limited stock price is $1459.1 today.

Is Ipca Laboratories Limited stock public?

Yes, Ipca Laboratories Limited is a publicly traded company.

Something similar

Top by Market Cap
M&M.NS
MIX.JO
FB2A.DE
AMZN
EMBASSY.NS
Top Correlated ETFs
TRIA.L
Top Correlated Stocks
1820.HK
3769.T
8750.T
6676.T
7455.T
Similar Market Cap
0669.HK
ISEC.NS
AMD
2912.TW
4751.T

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 563.32K
  • Market Capitalization 339.71B
  • Employee 16.17K
  • CEO Mr. Pranay Premchand Godha
  • Headquarters Mumbai,IN
  • IPO Date 1996-01-01
  • Website https://www.ipca.com

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.